The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Prognostic impact of tumour‐infiltrating B cells and plasma cells in colorectal cancer
Open accessAbstract
Multiple studies have described associations between infiltrating immune cells and prognosis in cancer; however, the clinical relevance has most often been attributed to the T‐cell linage. This study aimed to further investigate the clinicopathological correlates and prognostic impact of B cell and plasma cell infiltration in CRC. Immunohistochemical expression of CD20, CD138 and immunoglobulin kappa C (IGKC) was analysed in tissue microarrays with tumours from 557 incident cases of CRC from a prospective population‐based cohort. Kaplan–Meier analysis and Cox regression analysis were used to determine the impact of CD20, CD138 and IGKC expression on 5‐year overall survival. Immune cell‐specific CD20, CD138, and IGKC expression correlated significantly with lower T‐stage (p < 0.001, p < 0.001, and p = 0.006, respectively). A higher density of CD20+ cells correlated significantly with an improved OS (HR = 0.53, 95% CI 0.36–0.78), remaining significant in multivariable analysis adjusted for age, TNM stage, differentiation grade and vascular invasion (HR = 0.51; 95% CI 0.33–0.80). Immune cell‐specific CD138 and IGKC expression correlated significantly with an improved OS in univariable Cox regression analysis; however, these associations did not remain significant in multivariable analysis. Finally, tumour cell‐specific CD138 expression was found to be an independent factor of poor prognosis (HR 1.52; 95% CI 1.03–2.24). The results from the present study demonstrate that B cell infiltration in CRC has a significant impact on tumour progression and prognosis. These findings supplement and extend the current knowledge of the immune landscape in colorectal cancer, and merit further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Lynch, T. J., Bondarenko, I., Luft, A., Serwatowski, P., Barlesi, F., Chacko, R., Sebastian, M., Neal, J., Lu, H., Cuillerot, J.-M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4032 · Cited by 1,002
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
BERGLUND, G., ELMSTÅHL, S., JANZON, L., & LARSSON, S. A. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00647.x · Cited by 640
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Nielsen, J. S., Sahota, R. A., Milne, K., Kost, S. E., Nesslinger, N. J., Watson, P. H., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0234 · Cited by 553
Manjer, J., Carlsson, S., Elmståhl, S., Gullberg, B., Janzon, L., Lindström, M., Mattisson, I., & Berglund, G. (2001) · European Journal of Cancer Prevention · doi:10.1097/00008469-200112000-00003 · Cited by 542
Tumour immunity: effector response to tumour and role of the microenvironment
Mantovani, A., Romero, P., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 537
Immune surveillance: a balance between protumor and antitumor immunity
Ostrand-Rosenberg, S. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.007 · Cited by 480
Milne, K., Köbel, M., Kalloger, S. E., Barnes, R. O., Gao, D., Gilks, C. B., Watson, P. H., & Nelson, B. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006412 · Cited by 446
Tissue microarrays for gene amplification surveys in many different tumor types.
Schraml, P., Kononen, J., Bubendorf, L., Moch, H., Bissig, H., Nocito, A., Mihatsch, M. J., Kallioniemi, O., & Sauter, G. (1999) · PubMed · Cited by 433
Ogino, S., Nosho, K., Irahara, N., Meyerhardt, J. A., Baba, Y., Shima, K., Glickman, J. N., Ferrone, C. R., Mino-Kenudson, M., Tanaka, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1438 · Cited by 418
DiLillo, D. J., Yanaba, K., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903009 · Cited by 359
Clinical Relevance of Microsatellite Instability in Colorectal Cancer
de la Chapelle, A., & Hampel, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0652 · Cited by 332
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Affara, N. I., Ruffell, B., Medler, T. R., Gunderson, A. J., Johansson, M., Bornstein, S., Bergsland, E., Steinhoff, M., Li, Y., Gong, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.026 · Cited by 304
The prognostic significance of B lymphocytes in invasive carcinoma of the breast
Mahmoud, S. M. A., Lee, A. H. S., Paish, E. C., Macmillan, R. D., Ellis, I. O., & Green, A. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1620-1 · Cited by 261
Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
Cipponi, A., Mercier, M., Seremet, T., Baurain, J.-F., Théate, I., van den Oord, J., Stas, M., Boon, T., Coulie, P. G., & van Baren, N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1377 · Cited by 259
Schmidt, M., Hellwig, B., Hammad, S., Othman, A., Lohr, M., Chen, Z., Boehm, D., Gebhard, S., Petry, I., Lebrecht, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2210 · Cited by 253
Self-citationShi, J.-Y., Gao, Q., Wang, Z.-C., Zhou, J., Wang, X.-Y., Min, Z.-H., Shi, Y.-H., Shi, G.-M., Ding, Z.-B., Ke, A.-W., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3497 · Cited by 240
Diederichsen, A. C. P., v. B. Hjelmborg, J., Christensen, P. B., Zeuthen, J., & Fenger, C. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0388-5 · Cited by 237
Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H.-M., Newman, C. L., Shin, S.-U., Nechustan, H., Challita-Eid, P. M., Segal, B. M., Yi, K. H., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21177 · Cited by 227
Lohr, M., Edlund, K., Botling, J., Hammad, S., Hellwig, B., Othman, A., Berglund, A., Lambe, M., Holmberg, L., Ekman, S., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.036 · Cited by 214
Self-citationMohammed, Z. M. A., Going, J. J., Edwards, J., Elsberger, B., & McMillan, D. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.493 · Cited by 147
Meshcheryakova, A., Tamandl, D., Bajna, E., Stift, J., Mittlboeck, M., Svoboda, M., Heiden, D., Stremitzer, S., Jensen‐Jarolim, E., Gruenberger, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099008 · Cited by 118
Nedergaard, B. S., Ladekarl, M. B., Nyengaard, J. R., & Nielsen, K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.089 · Cited by 115
Tissue microarrays for miniaturized high-throughput molecular profiling of tumors
Simon, R., & Sauter, G. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00965-7 · Cited by 109
Larsson, A.-M., Johansson, M. E., Wangefjord, S., Gaber, A., Nodin, B., Kucharzewska, P., Welinder, C., Belting, M., Eberhard, J., Johnsson, A., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.295 · Cited by 100
Self-citationShed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer
Wang, X., Zuo, D., Chen, Y., Li, W., Liu, R., He, Y., Ren, L., Zhou, L., Deng, T., Wang, X., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.493 · Cited by 95
Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model
Julien, S., Picco, G., Sewell, R., Vercoutter‐Edouart, A., Tarp, M. S., Miles, D. W., Clausen, H., Taylor-Papadimitriou, J., & Burchell, J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605083 · Cited by 94
Chapoval, A. I., Fuller, J. A., Kremlev, S. G., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6977 · Cited by 89
Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier, M. P., Edwardes, M., Michel, R. P., Halwani, F., & Morin, J. E. (2001) · Europe PMC (PubMed Central) · Cited by 88
Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours
Mennerich, D., Vogel, A., Klaman, I., Dahl, E., Lichtner, R. B., Rosenthal, A., Pohlenz, H.-D., Thierauch, K.-H., & Sommer, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.038 · Cited by 79
The immune response in cancer: from immunology to pathology to immunotherapy
Giraldo, N. A., Becht, É., Vano, Y. A., Sautès‐Fridman, C., & Fridman, W. H. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1787-7 · Cited by 59
Wangefjord, S., Manjer, J., Gaber, A., Nodin, B., Eberhard, J., & Jirström, K. (2011) · Biology of Sex Differences · doi:10.1186/2042-6410-2-10 · Cited by 42
Self-citationImmunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer
Chen, Z., Gerhold‐Ay, A., Gebhard, S., Boehm, D. U., Solbach, C., Lebrecht, A., Battista, M. J., Sicking, I., Cotarelo, C., Cadenas, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044741 · Cited by 37
Wangefjord, S., Sundström, M., Zendehrokh, N., Lindquist, K. E., Nodin, B., Jirström, K., & Eberhard, J. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-17 · Cited by 36
Self-citationClinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer
Liao, Y., Ou, J., Deng, J., Geng, P., Zeng, R., Tian, Y., Liang, H., Ni, B., & Ruan, Z. (2013) · Medical Oncology · doi:10.1007/s12032-013-0727-0 · Cited by 19
Cited by
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Tumor-infiltrating lymphocytes in the immunotherapy era
Paijens, S. T., Vledder, A., de Bruyn, M., & Nijman, H. W. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00565-9 · Cited by 880
Fridman, W. H., Meylan, M., Petitprez, F., Sun, C.-M., Italiano, A., & Sautès-Fridman, C. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00619-z · Cited by 657
Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
Wouters, M. C. A., & Nelson, B. H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1481 · Cited by 495
Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Garaud, S., Buisseret, L., Solinas, C., Gu-Trantien, C., de Wind, A., Van den Eynden, G., Naveaux, C., Lodewyckx, J.-N., Boisson, A., Duvillier, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129641 · Cited by 347
Metadata
- Authors
- Berntsson, J., Nodin, B., Eberhard, J., Micke, P., & Jirström, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2016-05-06
- Volume
- 139
- Issue
- 5
- Pages
- 1129-1139
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2342031461
- Cited by
- 253
- References
- 47
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.